• Home
• About Us
  • Company
  • History
  • Management
  • Brochure (pdf)
• Drug Discovery
  • SKIL® Platform
  • Drug Discovery Programmes
  • Chk1 Kinase
  • Aurora+FLT3 & ALK Kinases
  • VEGFR-3 Kinase
  • FLT3 Kinase
  • TYK2 Kinase
  • Other Programmmes
• Partnering
  • Out-licensing
• Investors
  • Board of Directors
  • Information Disclosure
  • Investor News
  • Company Advisers
  • Research Notes
• News & Events
  • Press Release
  • Publications & News
  • Events
• Contact Us
  • Careers
  • Contact Us
  • Map & Directions

Requires RSS news reader

Requires MS Word

Requires Adobe Acrobat Reader